Cytologic identification of serous neoplasms in peritoneal fluids.
BACKGROUND
Recognition of serous neoplasms in peritoneal fluids and their subclassification into serous borderline tumors (SBT) and serous carcinomas (SCA) may be difficult. The objective of this study was to determine whether morphologic criteria can distinguish reactive mesothelial cells (RM), SBT, and SCA (grades 1-3) in peritoneal fluids.


METHODS
A blinded review of 42 peritoneal fluids from 40 patients with histologically confirmed RM (n = 10 patients), SBT (n = 7 patients; 3 with primary ovarian tumors and 4 with primary peritoneal tumors), and SCA (n = 23 patients; 7 with grade 1 tumors, 6 with grade 2 tumors, and 10 with grade 3 tumors; 12 with primary ovarian tumors and 11 with primary peritoneal tumors) evaluated papillae presence and size, intercellular windows, group contours, dyshesion, nuclear atypia, size and overlap, cell size, and nucleoli and nuclear-to-cytoplasmic ratios. From these parameters, specimens were classified as RM, SBT versus grade 1 SCA, or grade 2 SCA versus grade 3 SCA.


RESULTS
RM were identified as groups of small cells with minimal nuclear atypia and overlap, intercellular windows, and irregular group borders without papillae. No features differentiated SBT from grade 1 SCA. Grade 2 and 3 SCA showed more nuclear atypia and overlap with larger nuclei and cells. Thirty-nine of 42 specimens (95%) were correctly identified as RM or serous neoplasm. Two SBT specimens and one grade 1 SCA specimen were overcalled, and three SCA specimens (two grade 2 and one grade 3) were undergraded.


CONCLUSIONS
The distinction of RM from serous neoplasms in peritoneal fluids is possible in most patients by examination of cell group architecture, nuclear atypia, and nuclear size. Differentiation of SBT from grade 1 SCA is not reliable, meriting a differential diagnosis. Most high-grade SCA specimens can be identified by increased nuclear atypia, overlap, and size.
Weir
M M
MM
Department of Pathology, University Health Network, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada.
Bell
D A
DA
D000328:Adult; D000368:Aged; D001202:Ascitic Fluid / Q000166:cytology*; D018284:Cystadenocarcinoma, Serous / Q000473:pathology*; D018293:Cystadenoma, Serous / Q000473:pathology*; D003937:Diagnosis, Differential; D004848:Epithelium / Q000473:pathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000473:pathology*; D011237:Predictive Value of Tests